BioCentury
ARTICLE | Financial News

Edge raises $72.5M in additional series C rounds

April 10, 2015 1:08 AM UTC

Neurology company Edge Therapeutics Inc. (Berkeley Heights, N.J.) raised a combined $72.5 million in series C-1 and C-2 rounds.

Edge raised $56 million this month in a C-2 round led by Venrock. Sofinnova Ventures; Janus Capital Management; funds managed by Franklin Advisers; New Leaf Venture Partners; and BioMed Ventures also participated. Credit Suisse and Leerink were placement agents. ...